Product NDC: | 51808-127 |
Proprietary Name: | P32 Sodium Phosphate |
Non Proprietary Name: | P32 Sodium Phosphate |
Active Ingredient(s): | 5 mCi/mL & nbsp; P32 Sodium Phosphate |
Administration Route(s): | INTERSTITIAL; INTRA-ARTICULAR; INTRAPERITONEAL; INTRAPLEURAL |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51808-127 |
Labeler Name: | AnazaoHealth Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20120619 |
Package NDC: | 51808-127-01 |
Package Description: | 3 mL in 1 VIAL (51808-127-01) |
NDC Code | 51808-127-01 |
Proprietary Name | P32 Sodium Phosphate |
Package Description | 3 mL in 1 VIAL (51808-127-01) |
Product NDC | 51808-127 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | P32 Sodium Phosphate |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTERSTITIAL; INTRA-ARTICULAR; INTRAPERITONEAL; INTRAPLEURAL |
Start Marketing Date | 20120619 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | AnazaoHealth Corporation |
Substance Name | PHOSPHORUS P-32 |
Strength Number | 5 |
Strength Unit | mCi/mL |
Pharmaceutical Classes |